1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics in North America Countries, April 2016 (p7)

Biopharmaceutical Analysis & Statistics in North America Countries, April 2016 (p7)

181-210 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Industry report
  • April 2016
  • by Global Data

Summary Provectus Biopharmaceuticals, Inc. (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States
Symic Biomedical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Symic Biomedical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Symic Biomedical, Inc. (Symic Biomedical) is a biopharmaceutical company that develops library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related ...

  • Industries : Biopharmaceutical
  • Countries : United States
Vaxart, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vaxart, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Vaxart, Inc. (Vaxart) is a biotechnology company that develops and manufactures oral delivery vaccines to prevent viral based infectious diseases. The company’s products include adjuvanted oral ...

  • Industries : Biopharmaceutical, Drug and Medication, Biotechnology, Pharmaceutical
  • Countries : United States
PaxVax, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PaxVax, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary PaxVax, Inc. (PaxVax) is a biotechnology company that develops and commercializes vaccines against infectious diseases. The company’s products include PXVX0200, Vivotif and PXVX0103. It’s PXVX0200, ...

  • Industries : Biopharmaceutical, Drug and Medication
  • Countries : United States
Ondine Biomedical Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ondine Biomedical Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Ondine Biomedical Inc. (Ondine), formerly Ondine Biopharma Corporation is a biotechnology and medical device company that develops non-antibiotics and anti-infective therapies for a broad spectrum ...

  • Countries : Canada
Provectus Biopharmaceuticals, Inc. (PVCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Provectus Biopharmaceuticals, Inc. (PVCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Provectus Biopharmaceuticals, Inc. (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States
MP Biomedicals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MP Biomedicals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary MP Biomedicals, LLC (MP Biomedicals) is a diagnostic company that manufactures and markets life science, fine chemical and diagnostic products. Its life science products include adsorbents, antibodies ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
GlaxoSmithKline Plc - Strategy and SWOT Report

GlaxoSmithKline Plc - Strategy and SWOT Report

  • $ 175
  • Company report
  • March 2016
  • by MarketLine

GlaxoSmithKline Plc - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical
  • Countries : United States, World
Omega Protein Corporation

Omega Protein Corporation

  • $ 99
  • Company report
  • May 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Omega Protein Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biopharmaceutical, Hospitality, Hospitality, Biotechnology
  • Countries : United States
Alder Biopharmaceuticals Inc

Alder Biopharmaceuticals Inc

  • $ 99
  • Company report
  • May 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Alder Biopharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States, World
Epirus Biopharmaceuticals Inc

Epirus Biopharmaceuticals Inc

  • $ 99
  • Company report
  • May 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Epirus Biopharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States, World
VBI Vaccines Incorporation

VBI Vaccines Incorporation

  • $ 99
  • Company report
  • April 2016
  • by Wright Investors' Service

A textual analysis of the financial results for VBI Vaccines Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2 995
  • Industry report
  • March 2016
  • by Currentpartnering

The Global Antibody Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 1 995
  • Industry report
  • March 2016
  • by Currentpartnering

The Global Cancer Monoclonal Antibody Partnering 2010-2016: Deal trends, players, financials and forecasts report provides an understanding and access to the cancer monoclonal antibody partnering deals ...

  • Industries : Pharmaceutical, Biopharmaceutical, Pathology, General Medicine and Specialty Medicine, Biotechnology, Healthcare
  • Countries : United States
Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2 995
  • Industry report
  • March 2016
  • by Currentpartnering

The Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and ...

  • Industries : Pharmaceutical, Biotechnology, Biopharmaceutical, Drug and Medication, Healthcare, Pathology, Biological Therapy
  • Countries : United States, North America
Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials

Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials

  • $ 2 995
  • Industry report
  • March 2016
  • by Currentpartnering

The Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials report provides a detailed understanding and analysis of how and why companies enter infectious ...

  • Industries : Biopharmaceutical, Biotechnology, Drug and Medication, Pharmaceutical, Healthcare, Biological Therapy
  • Countries : United States, North America
Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2 995
  • Industry report
  • March 2016
  • by Currentpartnering

The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies ...

  • Industries : Pharmaceutical, Biopharmaceutical, Biotechnology, Pathology, Healthcare, General Medicine and Specialty Medicine
  • Countries : United States
Rheumatoid Arthritis: KOL Insight

Rheumatoid Arthritis: KOL Insight

  • $ 8 085
  • Industry report
  • March 2016
  • by Firstword Pharma

Leading brands under threat as biosimilars and new pipeline drugs hit the market Key opinion leaders (KOLs) say Rheumatoid Arthritis (RA) treatment is in for a shakeup thanks to anti-TNF biosimilars, new ...

  • Industries : Biopharmaceutical
  • Countries : United States, Europe
Pharmaceutical Industry in the United States 2016

Pharmaceutical Industry in the United States 2016

  • $ 750
  • Industry report
  • March 2016
  • by Aruvian's R'search

Over the past decade, pharmaceutical companies have pushed the scientific envelope, working at the cellular and molecular levels to dramatically advance the treatment of disease. The US pharmaceutical ...

  • Industries : Pharmaceutical
  • Countries : United States, World, India, China, Asia
Genital Herpes - Pipeline Review, H1 2016

Genital Herpes - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Genital Herpes - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Genital Herpes - Pipeline Review, H1 2016’, provides an overview of the Genital Herpes pipeline landscape. The report provides ...

  • Industries : Biopharmaceutical, Drug and Medication, Biotechnology, Pharmaceutical
  • Countries : United States
Kolltan Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Kolltan Pharmaceuticals, Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Industry report
  • February 2016
  • by Global Markets Direct

Kolltan Pharmaceuticals, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Kolltan Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Kolltan ...

  • Industries : Pharmaceutical, Biopharmaceutical, Research and Development, Pathology
  • Countries : World, United States
Colitis - Pipeline Review, H1 2016

Colitis - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Colitis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Colitis - Pipeline Review, H1 2016’, provides an overview of the Colitis pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016’, provides an overview of the B-Cell ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Epstein-Barr Viral Infections - Pipeline Review, H1 2016

Epstein-Barr Viral Infections - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Epstein-Barr Viral Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H1 2016’, provides an overview of the Epstein-Barr Viral ...

  • Industries : Pathology, Biological Therapy, Pharmaceutical, Research and Development
  • Countries : United States
GlaxoSmithKline Plc - Product Pipeline Review - 2016

GlaxoSmithKline Plc - Product Pipeline Review - 2016

  • $ 1 500
  • Industry report
  • February 2016
  • by Global Markets Direct

GlaxoSmithKline Plc - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘GlaxoSmithKline Plc - Product Pipeline Review - 2016’, provides an overview of the GlaxoSmithKline Plc’s pharmaceutical ...

  • Industries : Pathology, Biopharmaceutical, Pharmaceutical, Drug and Medication, Biotechnology
  • Countries : United States
Influenza B Infections - Pipeline Review, H1 2016

Influenza B Infections - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Influenza B Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Influenza B Infections - Pipeline Review, H1 2016’, provides an overview of the Influenza B Infections pipeline ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical, Drug and Medication
  • Countries : United States, World
Myasthenia Gravis - Pipeline Review, H1 2016

Myasthenia Gravis - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Myasthenia Gravis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H1 2016’, provides an overview of the Myasthenia Gravis pipeline landscape. The ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016

Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Industry report
  • February 2016
  • by Global Markets Direct

Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Research and Development, Drug and Medication
  • Countries : United States
Eli Lilly and Company - Product Pipeline Review - 2016

Eli Lilly and Company - Product Pipeline Review - 2016

  • $ 1 500
  • Industry report
  • February 2016
  • by Global Markets Direct

Eli Lilly and Company - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Eli Lilly and Company - Product Pipeline Review - 2016’, provides an overview of the Eli Lilly and Company’s ...

  • Industries : Pathology
  • Countries : United States
Candidiasis - Pipeline Review, H1 2016

Candidiasis - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Candidiasis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Candidiasis - Pipeline Review, H1 2016’, provides an overview of the Candidiasis pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.